JPH10194917A - Antimicrobial and low-irritating cosmetic - Google Patents
Antimicrobial and low-irritating cosmeticInfo
- Publication number
- JPH10194917A JPH10194917A JP9017514A JP1751497A JPH10194917A JP H10194917 A JPH10194917 A JP H10194917A JP 9017514 A JP9017514 A JP 9017514A JP 1751497 A JP1751497 A JP 1751497A JP H10194917 A JPH10194917 A JP H10194917A
- Authority
- JP
- Japan
- Prior art keywords
- glycol
- cosmetic
- ether
- extract
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 33
- 230000000845 anti-microbial effect Effects 0.000 title claims abstract 3
- -1 triethylene glycol, mono- Chemical class 0.000 claims abstract description 29
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 25
- 235000005865 Symphytum officinale Nutrition 0.000 claims abstract description 22
- 150000005846 sugar alcohols Polymers 0.000 claims abstract description 20
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 16
- 150000005215 alkyl ethers Chemical class 0.000 claims abstract description 13
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims abstract description 11
- 241000196324 Embryophyta Species 0.000 claims abstract description 9
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims abstract description 9
- 241001442052 Symphytum Species 0.000 claims abstract description 6
- 239000000469 ethanolic extract Substances 0.000 claims abstract description 5
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims abstract description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 3
- 150000001983 dialkylethers Chemical class 0.000 claims abstract 4
- 150000001346 alkyl aryl ethers Chemical class 0.000 claims abstract 2
- 239000000284 extract Substances 0.000 claims description 33
- 230000000844 anti-bacterial effect Effects 0.000 claims description 32
- 235000011187 glycerol Nutrition 0.000 claims description 12
- 244000126014 Valeriana officinalis Species 0.000 claims description 8
- 241000792914 Valeriana Species 0.000 claims description 6
- 235000017468 valeriana Nutrition 0.000 claims description 6
- 230000000774 hypoallergenic effect Effects 0.000 claims description 5
- 235000013832 Valeriana officinalis Nutrition 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 235000016788 valerian Nutrition 0.000 claims description 4
- 241000894007 species Species 0.000 claims description 3
- 239000004599 antimicrobial Substances 0.000 claims description 2
- 239000002798 polar solvent Substances 0.000 claims description 2
- 239000002085 irritant Substances 0.000 claims 3
- 150000002170 ethers Chemical class 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract description 9
- 208000002193 Pain Diseases 0.000 abstract description 6
- 230000000622 irritating effect Effects 0.000 abstract description 3
- 230000001235 sensitizing effect Effects 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 23
- 235000019198 oils Nutrition 0.000 description 23
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 22
- 229940060184 oil ingredients Drugs 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- 238000004519 manufacturing process Methods 0.000 description 18
- 240000002299 Symphytum officinale Species 0.000 description 17
- 239000012071 phase Substances 0.000 description 17
- 239000000203 mixture Substances 0.000 description 16
- 239000008346 aqueous phase Substances 0.000 description 15
- 239000008213 purified water Substances 0.000 description 15
- 239000003205 fragrance Substances 0.000 description 14
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 12
- 229940058015 1,3-butylene glycol Drugs 0.000 description 11
- 235000019437 butane-1,3-diol Nutrition 0.000 description 11
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 11
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 235000021355 Stearic acid Nutrition 0.000 description 9
- 239000000839 emulsion Substances 0.000 description 9
- 238000000605 extraction Methods 0.000 description 9
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 9
- 239000008117 stearic acid Substances 0.000 description 9
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 8
- 239000006071 cream Substances 0.000 description 8
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 8
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 8
- 239000004166 Lanolin Substances 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- 235000019388 lanolin Nutrition 0.000 description 7
- 229940039717 lanolin Drugs 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 206010040880 Skin irritation Diseases 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 230000036556 skin irritation Effects 0.000 description 6
- 231100000475 skin irritation Toxicity 0.000 description 6
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 229960000541 cetyl alcohol Drugs 0.000 description 5
- 229940075507 glyceryl monostearate Drugs 0.000 description 5
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 4
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 4
- 239000000440 bentonite Substances 0.000 description 4
- 229910000278 bentonite Inorganic materials 0.000 description 4
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 4
- 229960003237 betaine Drugs 0.000 description 4
- 239000000084 colloidal system Substances 0.000 description 4
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000000855 fungicidal effect Effects 0.000 description 4
- 239000000417 fungicide Substances 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- 229940057995 liquid paraffin Drugs 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 229920001059 synthetic polymer Polymers 0.000 description 4
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 4
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical class NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 3
- 239000002280 amphoteric surfactant Substances 0.000 description 3
- 230000002421 anti-septic effect Effects 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 3
- 229940105990 diglycerin Drugs 0.000 description 3
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000002453 shampoo Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 235000011076 sorbitan monostearate Nutrition 0.000 description 3
- 239000001587 sorbitan monostearate Substances 0.000 description 3
- 229940035048 sorbitan monostearate Drugs 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- OOWQBDFWEXAXPB-UHFFFAOYSA-N 1-O-palmitylglycerol Chemical compound CCCCCCCCCCCCCCCCOCC(O)CO OOWQBDFWEXAXPB-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 2
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 2
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 2
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 2
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- 235000021360 Myristic acid Nutrition 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 239000006229 carbon black Substances 0.000 description 2
- 235000013869 carnauba wax Nutrition 0.000 description 2
- 239000004203 carnauba wax Substances 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 229940082500 cetostearyl alcohol Drugs 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 229960005150 glycerol Drugs 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940051250 hexylene glycol Drugs 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 2
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 2
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000010199 sorbic acid Nutrition 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- 229940075582 sorbic acid Drugs 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- NRWMBHYHFFGEEC-KTKRTIGZSA-N (9Z)-1-O-octadec-9-enyl glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCCOCC(O)CO NRWMBHYHFFGEEC-KTKRTIGZSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- QWOZZTWBWQMEPD-UHFFFAOYSA-N 1-(2-ethoxypropoxy)propan-2-ol Chemical compound CCOC(C)COCC(C)O QWOZZTWBWQMEPD-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- JPPRXACMNPYJNK-UHFFFAOYSA-N 1-docosoxydocosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCCCCCC JPPRXACMNPYJNK-UHFFFAOYSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- RRQYJINTUHWNHW-UHFFFAOYSA-N 1-ethoxy-2-(2-ethoxyethoxy)ethane Chemical compound CCOCCOCCOCC RRQYJINTUHWNHW-UHFFFAOYSA-N 0.000 description 1
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 1
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- JHDNFMVFXUETMC-UHFFFAOYSA-N 2-(2H-benzotriazol-4-yl)-4-methylphenol Chemical compound CC1=CC=C(O)C(C=2C=3N=NNC=3C=CC=2)=C1 JHDNFMVFXUETMC-UHFFFAOYSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- BHIZVZJETFVJMJ-UHFFFAOYSA-N 2-hydroxypropyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(C)O BHIZVZJETFVJMJ-UHFFFAOYSA-N 0.000 description 1
- CNXZMGRWEYQCOQ-UHFFFAOYSA-N 2-methoxy-3-phenylprop-2-enoic acid Chemical class COC(C(O)=O)=CC1=CC=CC=C1 CNXZMGRWEYQCOQ-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- QCAHUFWKIQLBNB-UHFFFAOYSA-N 3-(3-methoxypropoxy)propan-1-ol Chemical compound COCCCOCCCO QCAHUFWKIQLBNB-UHFFFAOYSA-N 0.000 description 1
- GBSGXZBOFKJGMG-UHFFFAOYSA-N 3-propan-2-yloxypropan-1-ol Chemical compound CC(C)OCCCO GBSGXZBOFKJGMG-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 241000384508 Hoplostethus atlanticus Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- KIENGQUGHPTFGC-JLAZNSOCSA-N L-ascorbic acid 6-phosphate Chemical compound OP(=O)(O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O KIENGQUGHPTFGC-JLAZNSOCSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- MJNIWUJSIGSWKK-BBANNHEPSA-N Riboflavin butyrate Chemical compound CCCC(=O)OC[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)CN1C2=CC(C)=C(C)C=C2N=C2C1=NC(=O)NC2=O MJNIWUJSIGSWKK-BBANNHEPSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 206010040830 Skin discomfort Diseases 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 240000002871 Tectona grandis Species 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- RKFMOTBTFHXWCM-UHFFFAOYSA-M [AlH2]O Chemical compound [AlH2]O RKFMOTBTFHXWCM-UHFFFAOYSA-M 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 125000001769 aryl amino group Chemical group 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 229960001716 benzalkonium Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229940050390 benzoate Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000012730 carminic acid Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940071120 dehydroacetate Drugs 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 229960002086 dextran Drugs 0.000 description 1
- 229940019778 diethylene glycol diethyl ether Drugs 0.000 description 1
- 229940028356 diethylene glycol monobutyl ether Drugs 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- IQDGSYLLQPDQDV-UHFFFAOYSA-N dimethylazanium;chloride Chemical compound Cl.CNC IQDGSYLLQPDQDV-UHFFFAOYSA-N 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- CHELXPVQXZGRDI-UHFFFAOYSA-N diphenylmethanone;(2-hydroxy-4-methoxyphenyl)-phenylmethanone Chemical class C=1C=CC=CC=1C(=O)C1=CC=CC=C1.OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 CHELXPVQXZGRDI-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- IHSPMDXQWYKHOA-UHFFFAOYSA-N dodecyl 2-(dimethylamino)acetate Chemical compound CCCCCCCCCCCCOC(=O)CN(C)C IHSPMDXQWYKHOA-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229960003399 estrone Drugs 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical class OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000001055 magnesium Nutrition 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- JCGNDDUYTRNOFT-UHFFFAOYSA-N oxolane-2,4-dione Chemical compound O=C1COC(=O)C1 JCGNDDUYTRNOFT-UHFFFAOYSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 150000002948 pantothenic acids Chemical class 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 208000017983 photosensitivity disease Diseases 0.000 description 1
- 231100000434 photosensitization Toxicity 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- CHWRSCGUEQEHOH-UHFFFAOYSA-N potassium oxide Chemical compound [O-2].[K+].[K+] CHWRSCGUEQEHOH-UHFFFAOYSA-N 0.000 description 1
- 229910001950 potassium oxide Inorganic materials 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 229940026235 propylene glycol monolaurate Drugs 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 239000011755 sodium-L-ascorbate Substances 0.000 description 1
- 235000019187 sodium-L-ascorbate Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- IFYFNVDTVZKNBZ-UHFFFAOYSA-N tetradecyl 2-hydroxybenzoate Chemical compound CCCCCCCCCCCCCCOC(=O)C1=CC=CC=C1O IFYFNVDTVZKNBZ-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】この発明は、優れた抗菌性を
有し、細菌,カビなどの微生物により汚染されることの
ない、安定で且つ皮膚に対する刺激性の低い化粧料に関
する。さらに詳しくは、多価アルコール及び多価アルコ
ールのアルキルエーテルより選んだ1種又は2種以上
と、ヒレハリソウ属植物の抽出物を併用してなる抗菌性
の高い低刺激化粧料に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a cosmetic composition which has excellent antibacterial properties, is not contaminated by microorganisms such as bacteria and mold, is stable and has low skin irritation. More specifically, the present invention relates to a highly antibacterial and hypoallergenic cosmetic composition obtained by using one or more kinds selected from polyhydric alcohols and alkyl ethers of polyhydric alcohols in combination with an extract of a plant of the genus Valerian.
【0002】[0002]
【従来の技術】従来、化粧水,乳液,クリーム等、水を
含有する化粧料においては、製造時及び使用時における
細菌,かび等の微生物の混入による変質を防止するた
め、種々の防腐防黴剤が使用されてきた。かかる防腐剤
としては、イソプロピルメチルフェノール,パラオキシ
安息香酸エステル,フェノキシエタノール,ヒノキチオ
ール等のフェノール類、安息香酸及びその塩,サリチル
酸及びその塩,デヒドロ酢酸及びその塩,ソルビン酸及
びその塩などの酸類、塩化ベンザルコニウム,塩化ベン
ゼトニウム,塩化アルキルトリメチルアンモニウム等の
第4級アンモニウム類、塩酸アルキルアミノエチルグリ
シン,塩化ステアリルヒドロキシエチルベタインナトリ
ウム等の両性界面活性剤、感光素などが用いられてい
る。2. Description of the Related Art Conventionally, cosmetics containing water, such as lotions, emulsions, creams, etc., have various antiseptic and antifungal agents in order to prevent deterioration due to the incorporation of microorganisms such as bacteria and mold during production and use. Agents have been used. Examples of such preservatives include phenols such as isopropylmethylphenol, paraoxybenzoate, phenoxyethanol and hinokitiol; benzoic acid and its salts; salicylic acid and its salts; dehydroacetic acid and its salts; sorbic acid and its salts; Quaternary ammoniums such as benzalkonium, benzethonium chloride and alkyltrimethylammonium chloride, amphoteric surfactants such as alkylaminoethylglycine hydrochloride and sodium stearylhydroxyethylbetaine chloride, and photosensitizers are used.
【0003】しかし、上記の防腐防黴剤には皮膚に対す
る一次刺激性,感作性或いは光感作性の報告されている
ものが多く、安全性の面から化粧品原料基準において配
合量が規制されており、実際に有効な抗菌活性を示す量
を配合できないことが多い。さらに、皮膚に対して発
赤,発疹,浮腫といった刺激或いは感作反応を示さなく
ても、化粧料を使用する際に、刺すような痛みやヒリヒ
リする感じ又はチクチクする感じといった不快感を与え
ることも知られている。また、化粧料の基剤や他の配合
成分との相互作用により、充分な抗菌活性を示さない場
合もある。However, many of the above-mentioned preservatives and fungicides have been reported to have primary irritation, sensitization or photosensitization to the skin, and the amount of the preservative and fungicide is regulated based on the standard of cosmetic raw materials from the viewpoint of safety. In many cases, it is not possible to incorporate an amount showing an effective antibacterial activity. Further, even when the cosmetic does not show a stimulating or sensitizing reaction such as redness, rash, or edema to the skin, it may cause discomfort such as stinging, burning, or tingling when using the cosmetic. Are known. In addition, due to the interaction with the base of the cosmetic or other compounding components, there may be cases where sufficient antibacterial activity is not exhibited.
【0004】例えば、イソプロピルメチルフェノール,
パラオキシ安息香酸エステル,ソルビン酸等の油溶性防
腐防黴剤は、高分子増粘剤や粉体を含む化粧料に配合し
た場合、吸着等により抗菌活性が低下する。また、界面
活性剤を含有する化粧料においては、界面活性剤ミセル
への取り込みによりやはり抗菌活性の低下が見られる。
かといって、充分な抗菌活性を期待して多量に配合する
と、低温での結晶析出等、製品の安定性上の問題が生じ
る。For example, isopropylmethylphenol,
When oil-soluble preservatives and fungicides such as paraoxybenzoate and sorbic acid are added to cosmetics containing a polymer thickener or powder, the antibacterial activity is reduced by adsorption or the like. Further, in cosmetics containing a surfactant, the antibacterial activity is also reduced due to incorporation into surfactant micelles.
On the other hand, if a large amount is added in anticipation of a sufficient antibacterial activity, problems such as crystal precipitation at low temperatures and the like arise in product stability.
【0005】また、安息香酸塩,サリチル酸塩,デヒド
ロ酢酸塩等の水溶性防腐剤は、化粧料のpHが弱酸性で
ないと有効ではなく、酸性下にて使用する場合であって
も、酸性が強くなるに従い水に対する溶解度が低下し、
結晶の析出をきたすことがある。Water-soluble preservatives such as benzoate, salicylate and dehydroacetate are not effective unless the pH of the cosmetic is weakly acidic. As it becomes stronger, its solubility in water decreases,
Crystal precipitation may occur.
【0006】さらに、第4級アンモニウム類や両性界面
活性剤については、皮膚刺激性,眼粘膜刺激性が認めら
れたり、発泡しやすい,酸性側で抗菌活性が低下する,
陰イオン性物質との相互作用などの実使用上の問題があ
る。[0006] Further, quaternary ammoniums and amphoteric surfactants are irritating to the skin and mucous membranes of the eyes, and are liable to foam, and the antibacterial activity decreases on the acidic side.
There are practical problems such as interaction with anionic substances.
【0007】[0007]
【発明が解決しようとする課題】従って、本発明におい
ては、化粧料基剤や他の配合成分により抗菌活性が低下
することなく有効な抗菌作用を示し、且つ可能な限り防
腐防黴剤の配合量を少なくして、皮膚に対し一次刺激性
や感作性を示さないだけではなく、化粧料使用時の刺す
ような痛みやヒリヒリ感,チクチク感といった不快感を
も与えない化粧料を得ることを目的とした。Accordingly, in the present invention, an effective antibacterial action is exhibited without deteriorating the antibacterial activity by a cosmetic base or other compounding components, and a preservative or fungicide is added as much as possible. To obtain cosmetics that not only do not show primary irritation and sensitization to the skin but also do not cause discomfort such as stabbing pain, tingling or tingling when using cosmetics by reducing the amount Aimed at.
【0008】[0008]
【課題を解決するための手段】上記課題を解決するた
め、安定性が高く、皮膚に対する刺激性の低い防腐防黴
系を検討した結果、多価アルコール及び多価アルコール
のアルキルエーテルより選んだ1種又は2種以上と、ヒ
レハリソウ属植物の抽出物を併用して配合することによ
り、相乗的に抗菌活性が向上するばかりか、皮膚に対す
る刺激性や不快感が著しく低減することを見出だし、本
発明を完成するに至った。In order to solve the above problems, an antiseptic / fungicidal system having high stability and low irritation to the skin was examined, and as a result, a polyhydric alcohol and an alkyl ether of a polyhydric alcohol were selected. By combining the seed or two or more species with the extract of the genus Valeriana, not only synergistically improved antibacterial activity but also significantly reduced irritation and discomfort to the skin were found. The invention has been completed.
【0009】[0009]
【発明の実施の形態】本発明においては、通常化粧料原
料として使用される多価アルコールであれば用い得る
が、特に分子内に4個以下の水酸基を有するものが、相
乗的な抗菌活性を得る上で好ましい。例えば、エチレン
グリコール,ジエチレングリコール,トリエチレングリ
コール,プロピレングリコール,ジプロピレングリコー
ル,1,3-ブチレングリコール,3-メチル-1,3-ブタンジ
オール(イソプロピレングリコール),ヘキシレングリ
コール,グリセリン,ジグリセリンなどが例示され、こ
れらより、1種又は2種以上を選択して用いる。BEST MODE FOR CARRYING OUT THE INVENTION In the present invention, any polyhydric alcohol which is usually used as a raw material for cosmetics can be used. In particular, those having 4 or less hydroxyl groups in the molecule have a synergistic antibacterial activity. It is preferable for obtaining. For example, ethylene glycol, diethylene glycol, triethylene glycol, propylene glycol, dipropylene glycol, 1,3-butylene glycol, 3-methyl-1,3-butanediol (isopropylene glycol), hexylene glycol, glycerin, diglycerin, etc. And one or more of these are selected and used.
【0010】また、本発明において用いる多価アルコー
ルのアルキルエーテルとしては、グリコール類又はグリ
セリンのアルキルエーテルが好適に使用でき、とくに、
エチレングリコールモノメチルエーテル,エチレングリ
コールモノエチルエーテル(エチルエセロソルブ),エ
チレングリコールモノブチルエーテル(ブチルセロソル
ブ),エチレングリコールジメチルエーテル,ジエチレ
ングリコールモノメチルエーテル(メチルカルビトー
ル),ジエチレングリコールモノエチルエーテル(エチ
ルカルビトール),ジエチレングリコールモノブチルエ
ーテル,ジエチレングリコールジメチルエーテル,ジエ
チレングリコールジエチルエーテル,プロピレングリコ
ールモノメチルエーテル,プロピレングリコールモノエ
チルエーテル,プロピレングリコールモノイソプロピル
エーテル,ジプロピレングリコールモノメチルエーテ
ル,ジプロピレングリコールモノエチルエーテル,グリ
セリルモノパルミチルエーテル(キミルアルコール),
グリセリルモノステアリルエーテル(バチルアルコー
ル),グリセリルモノオレイルエーテル(セラキルアル
コール)等が好ましいものとして例示され、これらより
1種又は2種以上を選択して用いる。As the alkyl ether of a polyhydric alcohol used in the present invention, glycols or alkyl ethers of glycerin can be preferably used.
Ethylene glycol monomethyl ether, ethylene glycol monoethyl ether (ethyl eserosolve), ethylene glycol monobutyl ether (butyl cellosolve), ethylene glycol dimethyl ether, diethylene glycol monomethyl ether (methyl carbitol), diethylene glycol monoethyl ether (ethyl carbitol), diethylene glycol monobutyl ether , Diethylene glycol dimethyl ether, diethylene glycol diethyl ether, propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol monoisopropyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, glyceryl monopalmityl Ether (Kimi alcohol),
Glyceryl monostearyl ether (batyl alcohol), glyceryl monooleyl ether (serakyl alcohol) and the like are exemplified as preferable ones, and one or more of these are selected and used.
【0011】これら多価アルコール又は多価アルコール
のアルキルエーテルは、単独では5.0重量%以上で抗
菌活性を示すが、化粧料のような複雑な系に添加した場
合には、十分な抗菌作用が認められないことが多い。し
かし、本発明においては相乗的な抗菌活性の増強が認め
られ、5.0〜10.0重量%程度の配合で十分な抗菌
作用を示す。These polyhydric alcohols or alkyl ethers of the polyhydric alcohols alone exhibit antibacterial activity at 5.0% by weight or more, but when added to complex systems such as cosmetics, have a sufficient antibacterial activity. Is often not recognized. However, in the present invention, synergistic enhancement of the antibacterial activity is recognized, and a sufficient antibacterial effect is exhibited at a blending ratio of about 5.0 to 10.0% by weight.
【0012】本発明において、多価アルコール又は多価
アルコールのアルキルエーテルと併用するヒレハリソウ
属植物抽出物は、ヒレハリソウ属植物の全草又はそれら
の葉、茎、根、種子及び花のうち何れかを単独で、ある
いは2種以上を組み合わせて用いる。また、生のまま若
しくは乾燥した状態で抽出することができる。ヒレハリ
ソウ属植物でも特に抗菌活性の点からコンフリー(Symi
ngtonia officinale L.)の葉のエタノール若しくは含
水エタノール抽出物が好ましく用いられる。In the present invention, the extract of the genus Valeriana used in combination with the polyhydric alcohol or the alkyl ether of the polyhydric alcohol may be obtained by removing the whole plant of the valerian plant or any of its leaves, stems, roots, seeds and flowers. Used alone or in combination of two or more. Further, it can be extracted as is or in a dry state. Comfrey ( Symi)
ngtonia officinale L.) leaves or ethanol extract containing water.
【0013】抽出溶媒としても特に限定されないが、
水、エタノール,メタノール,1,3-ブチレングリコー
ル,グリセリン,ジグリセリン,ポリグリセリン,イソ
プロピルアルコール等のアルコール類、アセトン,エー
テル,テトラヒドロフラン等の有機溶媒等が例示され、
これらを単独で又は2種以上を混合して用いることがで
きる。また、抽出効率を高めるために界面活性剤を添加
してもよい。これらの抽出溶媒の中でも、エタノール,
1,3-ブチレングリコール及びこれらの水溶液等の極性溶
媒を用いた場合特に有効な抗菌活性が得られる。抽出の
際のヒレハリソウ属植物と溶媒との比率は特に限定され
るものではないが、ヒレハリソウ属植物1に対して溶媒
2〜1000重量倍、特に抽出操作、効率の点で5〜1
00重量倍が好ましい。Although the extraction solvent is not particularly limited,
Water, ethanol, methanol, 1,3-butylene glycol, glycerin, diglycerin, polyglycerin, alcohols such as isopropyl alcohol, organic solvents such as acetone, ether and tetrahydrofuran, and the like.
These can be used alone or in combination of two or more. Further, a surfactant may be added to enhance the extraction efficiency. Among these extraction solvents, ethanol,
Particularly effective antibacterial activity is obtained when polar solvents such as 1,3-butylene glycol and their aqueous solutions are used. The ratio of the Valerian plant to the solvent at the time of extraction is not particularly limited, but the solvent is 2 to 1000 times by weight relative to the Valerian plant 1, especially 5 to 1 in terms of extraction operation and efficiency.
00 weight times is preferred.
【0014】さらに、抽出方法としては、室温,冷却又
は加温した状態で含浸させて抽出する方法、水蒸気蒸留
等の蒸留法を用いて抽出する方法、生のヒレハリソウ属
植物から圧搾して抽出物を得る圧搾法等が例示され、こ
れらの方法を単独で又は2種以上を組み合わせて抽出を
行う。[0014] Further, as the extraction method, a method of extraction by impregnation at room temperature, in a cooled or heated state, a method of extraction using a distillation method such as steam distillation, an extract by pressing from a raw plant of the genus Valerian And the like. Extraction is performed using these methods alone or in combination of two or more.
【0015】また、このようにして得られたヒレハリソ
ウ属植物の抽出物は、抽出物をそのまま用いることもで
き、また防腐防黴作用を失わない範囲内で脱臭,精製等
の操作を加えてから配合することもでき、さらにはカラ
ムクロマトグラフィー等を用いて分画物としてもよい。
さらに、これらの抽出物や脱臭,精製物、分画物は、こ
れらから溶媒を除去することによって乾燥物とすること
もでき、さらにアルコールなどの溶媒に可溶化した形
態、或いは乳剤の形態で提供することができる。化粧料
への配合量は、0.01〜10重量%程度の低濃度で充
分である。The extract of the plant of the genus Valerian can be used as such, and the extract may be subjected to deodorization, purification, etc. within a range that does not lose the antiseptic and fungicidal action. It may be blended, and further, may be used as a fraction using column chromatography or the like.
Further, these extracts, deodorized, purified, and fractionated products can be dried by removing the solvent therefrom, and further provided in the form of a solution solubilized in a solvent such as alcohol or in the form of an emulsion. can do. A low amount of about 0.01 to 10% by weight is sufficient for the compounding amount in the cosmetic.
【0016】本発明にかかる化粧料としては、クリー
ム,軟膏,ローション,乳液,固形状,散剤など任意の
剤型とすることができ、化粧水,乳液,美容液,保湿ク
リーム等の基礎化粧料、日焼け止めクリーム,日焼け止
めローション,日焼けオイル,カーマインローション等
のサンケア商品、ファンデーション,アイライナー,マ
スカラ,アイカラー,チークカラー,口紅などのメイク
アップ化粧料、洗顔料,ボディーシャンプー,ヘアシャ
ンプー等の洗浄料、リンス,トリートメント,ヘアクリ
ーム,ヘアオイル,整髪剤などの毛髪用化粧料、香水、
防臭制汗剤等の形態で提供することができる。The cosmetic according to the present invention can be in any form such as cream, ointment, lotion, emulsion, solid, powder, etc., and basic cosmetics such as lotion, emulsion, serum, moisturizing cream, etc. Sun care products such as sunscreen creams, sunscreen lotions, suntan oils, carmine lotions, foundations, makeup cosmetics such as eyeliner, mascara, eye color, cheek color, lipstick, face wash, body shampoo, hair shampoo, etc. Hair cosmetics such as cleaning agents, rinses, treatments, hair creams, hair oils, hair styling agents, perfumes,
It can be provided in the form of a deodorant and antiperspirant.
【0017】その際、本発明の効果を損なわない範囲内
で、化粧料に一般的に用いられる各種成分、例えば、ア
ボカド油,パーム油,ピーナッツ油,コメヌカ油,ホホ
バ油,オレンジラフィー油,マカデミアナッツ油,スク
ワラン,月見草油,セサミ油,サンフラワー油,サフラ
ワー油,キャローラ油,カルナウバワックス,パラフィ
ンワックス,ラノリン,リンゴ酸ジイソステアリル,イ
ソステアリルアルコール,流動パラフィン等の油分、コ
ラーゲン,ヒアルロン酸等の保湿剤、ビタミンA油,レ
チノール,酢酸レチノール等のビタミンA類、リボフラ
ビン,酪酸リボフラビン等のビタミンB2類、塩酸ピリド
キシン等のビタミンB6類、L-アスコルビン酸,L-アスコ
ルビルリン酸マグネシウム,L-アスコルビン酸ナトリウ
ム等のビタミンC類、パントテン酸カルシウム,D-パン
トテニルアルコール,パントテニルエチルエーテル,ア
セチルパントテニルエチルエーテル等のパントテン酸
類、エルゴカルシフェロール,コレカルシフェロール等
のビタミンD類、ニコチン酸,ニコチン酸アミド,ニコ
チン酸ベンジル等のニコチン酸類、α-トコフェロール,
酢酸トコフェロール等のビタミンE類、ビタミンP、ビオ
チン等のビタミン類、2-ヒドロキシ-4-メトキシベンゾ
フェノン,2-ヒドロキシ-4-メトキシベンゾフェノン-5-
スルホン酸,2-ヒドロキシ-4-メトキシベンゾフェノン-
5-スルホン酸ナトリウム等のベンゾフェノン誘導体、パ
ラアミノ安息香酸,パラアミノ安息香酸エチル,パラジ
メチルアミノ安息香酸オクチル等のパラアミノ安息香酸
誘導体、パラメトキシ桂皮酸-2-エチルヘキシル,ジパラ
メトキシ桂皮酸モノ-2-エチルヘキサン酸グリセリル等
のメトキシ桂皮酸誘導体類、サリチル酸オクチル,サリ
チル酸ミリスチル等のサリチル酸誘導体、ウロカニン酸、
4-tert-ブチル-4'-メトキシジベンゾイルメタン、2-(2'-
ヒドロキシ-5'-メチルフェニル)ベンゾトリアゾール等
の紫外線吸収剤、グアガム,ローカストビーンガム,カ
ラギーナン,クインスシード,ペクチン,マンナン等の
植物系天然多糖類、キサンタンガム,デキストラン,カ
ードラン,ヒアルロン酸等の微生物系天然多糖類、ゼラ
チン,カゼイン,アルブミン,コラーゲン等の動物系高
分子、メチルセルロース,エチルセルロース,ヒドロキ
シエチルセルロース,ヒドロキシプロピルセルロース,
カルボキシメチルセルロース等のセルロース系半合成高
分子、可溶性デンプン,カルボキシメチルデンプン,メ
チルデンプン等のデンプン系半合成高分子、アルギン酸
プロピレングリコールエステル,アルギン酸塩等のアル
ギン酸系半合成高分子、ポリビニルアルコール,ポリビ
ニルピロリドン,カルボキシビニルポリマー,ポリアク
リル酸ナトリウム,ポリエチレンオキサイド等の合成高
分子、ベントナイト,ラポナイト,コロイダルアルミナ
等の無機物系高分子等の水溶性高分子、ジブチルヒドロ
キシトルエン,ブチルヒドロキシアニソール,没食子酸
エステル等の酸化防止剤、高級脂肪酸石鹸,アルキル硫
酸エステル塩,ポリオキシエチレンアルキルエーテル硫
酸塩,アシルメチルタウリン塩,アルキルエーテルリン
酸エステル塩,アシルアミノ酸塩等のアニオン界面活性
剤、塩化アルキルトリメチルアンモニウム,塩化ジアル
キルジメチルアンモニウム,塩化ベンザルコニウム等の
カチオン界面活性剤、アルキルジメチルアミノ酢酸ベタ
イン,アルキルアミドジメチルアミノ酢酸ベタイン,2-
アルキル-N-カルボキシメチル-N-ヒドロキシエチルイミ
ダゾリニウムベタインなどの両性界面活性剤、ポリオキ
シエチレンアルキルエーテル,ポリオキシエチレンアル
キルフェニルエーテル,ポリオキシエチレンポリオキシ
プロピレングリコール,ポリオキシエチレンポリオキシ
プロピレンアルキルエーテル,ポリオキシアルキレン脂
肪酸グリセリンエステル,ポリオキシアルキレンソルビ
タンエステル,ソルビット系オリゴマー型テトラエステ
ル,ソルビット系オリゴマー型ヘキサエステル,ポリエチ
レングリコールエステル,グリセリン脂肪酸エステル,ソ
ルビタン脂肪酸エステル,ショ糖脂肪酸エステル,アルキ
ロールアミド,脂肪酸アミド等のノニオン界面活性剤、
エチレンジアミン四酢酸ナトリウム塩,ポリリン酸ナト
リウム,クエン酸,メタリン酸ナトリウム,コハク酸,
グルコン酸等の金属イオン封鎖剤、胎盤抽出物,ソウハ
クヒエキス,グルタチオン,コウジ酸及びその誘導体
類,ハイドロキノン配糖体等のハイドロキノン及びその
誘導体類等の美白剤、グリチルリチン酸,グリチルレチ
ン酸,アラントイン,アズレン,ヒドロコルチゾン,ε
-アミノカプロン酸等の抗炎症剤、アラントインヒドロ
キシアルミニウム,塩化アルミニウム,タンニン酸,ク
エン酸,乳酸等の収れん剤、メントール,カンフル等の
清涼化剤、塩酸ジフェンヒドラミン,マレイン酸クロル
フェニラミン等の抗ヒスタミン剤、エストラジオール,
エストロン,エチニルエストラジオール等の皮脂抑制
剤、サリチル酸,レゾルシン等の角質剥離・溶解剤、α
−ヒドロキシ酸類等が配合できる。At this time, various components generally used in cosmetics, for example, avocado oil, palm oil, peanut oil, rice bran oil, jojoba oil, orange roughy oil, macadamia nut, so long as the effects of the present invention are not impaired. Oil, squalane, evening primrose oil, sesame oil, sunflower oil, safflower oil, carola oil, carnauba wax, paraffin wax, lanolin, diisostearyl malate, isostearyl alcohol, oils such as liquid paraffin, collagen, hyaluronic acid Humectants such as vitamin A oil, retinol, vitamin A such as retinol acetate, vitamin B 2 such as riboflavin and riboflavin butyrate, vitamin B 6 such as pyridoxine hydrochloride, L-ascorbic acid and magnesium L-ascorbyl phosphate C, such as sodium and sodium L-ascorbate , Calcium pantothenate, D-pantothenyl alcohol, pantothenic ethyl ether, acetyl pantothenyl ethyl ether, etc., pantothenic acids such as ergocalciferol, cholecalciferol, etc., nicotinic acid, nicotinamide, benzyl nicotinate Nicotinic acids such as α-tocopherol,
Vitamin E such as tocopherol acetate, vitamin P, vitamins such as biotin, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxybenzophenone-5-
Sulfonic acid, 2-hydroxy-4-methoxybenzophenone-
Benzophenone derivatives such as sodium 5-sulfonate; paraaminobenzoic acid derivatives such as paraaminobenzoic acid, ethyl paraaminobenzoate, octyl paradimethylaminobenzoate; 2-ethylhexyl paramethoxycinnamate; mono-2-ethylhexanoic acid diparamethoxycinnamate Methoxycinnamic acid derivatives such as glyceryl; salicylic acid derivatives such as octyl salicylate and myristyl salicylate; urocanic acid;
4-tert-butyl-4'-methoxydibenzoylmethane, 2- (2'-
UV absorbers such as (hydroxy-5'-methylphenyl) benzotriazole, natural plant polysaccharides such as guar gum, locust bean gum, carrageenan, quince seed, pectin, mannan, and microorganisms such as xanthan gum, dextran, curdlan, hyaluronic acid, etc. Animal natural polymers such as gelatin, casein, albumin, collagen, etc., methylcellulose, ethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose,
Cellulose-based semi-synthetic polymers such as carboxymethyl cellulose, starch-based semi-synthetic polymers such as soluble starch, carboxymethyl starch, and methyl starch; alginic acid-based semi-synthetic polymers such as propylene glycol alginate and alginate; polyvinyl alcohol; polyvinyl pyrrolidone , Carboxyvinyl polymers, synthetic polymers such as sodium polyacrylate and polyethylene oxide; water-soluble polymers such as bentonite, laponite and colloidal alumina; and dibutylhydroxytoluene, butylhydroxyanisole and gallic acid esters. Antioxidants, higher fatty acid soaps, alkyl sulfates, polyoxyethylene alkyl ether sulfates, acyl methyl taurine salts, alkyl ether phosphate salts, a Anionic surface active agents such as an arylamino acid salts, alkyl trimethyl ammonium chloride, dialkyl dimethyl ammonium chloride, cationic surfactants such as benzalkonium chloride, alkyl dimethyl amino acetic acid betaine, alkylamido betaine, 2-
Amphoteric surfactants such as alkyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine, polyoxyethylene alkyl ether, polyoxyethylene alkyl phenyl ether, polyoxyethylene polyoxypropylene glycol, polyoxyethylene polyoxypropylene alkyl Ether, polyoxyalkylene fatty acid glycerin ester, polyoxyalkylene sorbitan ester, sorbite oligomeric tetraester, sorbite oligomeric hexaester, polyethylene glycol ester, glycerin fatty acid ester, sorbitan fatty acid ester, sucrose fatty acid ester, alkylolamide, Nonionic surfactants such as fatty acid amides,
Sodium ethylenediaminetetraacetate, sodium polyphosphate, citric acid, sodium metaphosphate, succinic acid,
Sequestering agents such as gluconic acid, placental extracts, soybean arbor extract, glutathione, kojic acid and derivatives thereof, whitening agents such as hydroquinone and its derivatives such as hydroquinone glycosides, glycyrrhizic acid, glycyrrhetinic acid, alantoin, azulene , Hydrocortisone, ε
-Anti-inflammatory agents such as aminocaproic acid, astringents such as allantoin hydroxyaluminum, aluminum chloride, tannic acid, citric acid, and lactic acid; fresheners such as menthol and camphor; antihistamines such as diphenhydramine hydrochloride and chlorpheniramine maleate; estradiol ,
Sebum depressants such as estrone and ethinyl estradiol, exfoliants and dissolving agents such as salicylic acid and resorcinol, α
-Hydroxy acids and the like can be blended.
【0018】[0018]
【実施例】さらに本発明の特徴について、実施例により
詳細に説明する。まず、本発明で使用するヒレハリソウ
属植物の抽出物の製造方法を次に示す。EXAMPLES Further, the features of the present invention will be described in detail with reference to examples. First, a method for producing an extract of the genus Valeriana used in the present invention will be described below.
【0019】[製造例]コンフリー抽出物 乾燥して粉砕したコンフリーの葉30gと50重量%エ
タノール水溶液300mlを混合し、1時間環流させる。
フィルターで濾過して固形分を除去した後、溶媒を留去
し、乾燥物とする。得られた抽出物は、20重量%エタ
ノール水溶液300mlに溶解した。[Production Example] Comfrey extract 30 g of dried and crushed comfrey leaves and 300 ml of a 50% by weight aqueous ethanol solution are mixed and refluxed for 1 hour.
After removing the solid content by filtration with a filter, the solvent is distilled off to obtain a dried product. The obtained extract was dissolved in 300 ml of a 20% by weight aqueous ethanol solution.
【0020】 [実施例1]化粧水 (1)エタノール 7.0(重量%) (2)1,3-ブチレングリコール 10.0 (3)グリセリン 2.0 (4)ポリオキシエチレン硬化ヒマシ油 0.6 (5)コンフリー抽出物 1.0 (6)香料 0.06 (7)精製水 79.34 製法:(1)〜(6)の各成分を順次(7)に添加し、均一に
混合して調製する。Example 1 Lotion (1) Ethanol 7.0 (% by weight) (2) 1,3-butylene glycol 10.0 (3) Glycerin 2.0 (4) Polyoxyethylene hydrogenated castor oil 0 0.6 (5) Comfrey extract 1.0 (6) Fragrance 0.06 (7) Purified water 79.34 Production method: Add each component of (1) to (6) to (7) in order, and uniformly Prepare by mixing.
【0021】 [実施例2]乳液 (1)スクワラン 4.0(重量%) (2)トリ-2-エチルヘキサン酸グリセリル 2.0 (3)2-エチルヘキサン酸セチル 3.0 (4)セタノール 0.6 (5)ステアリルアルコール 0.4 (6)ソルビタンモノステアリン酸エステル 1.2 (7)1,3-ブチレングリコール 6.0 (8)ジプロピレングリコール 4.0 (9)ポリオキシエチレン(20EO)ソルビタン 0.8 モノステアリン酸エステル (10)精製水 75.9 (11)コンフリー抽出物 2.0 (12)香料 0.1 製法:まず、(1)〜(6)の油相を混合し、加熱融解して
75℃に保つ。一方(7)〜(10)の水相を混合し、加熱溶
解して75℃とし、これに前記油相を攪拌しながら添加
して乳化する。冷却後40℃にて(11),(12)を添加,混
合する。Example 2 Emulsion (1) Squalane 4.0 (% by weight) (2) Glyceryl tri-2-ethylhexanoate 2.0 (3) Cetyl 2-ethylhexanoate 3.0 (4) Cetanol 0.6 (5) Stearyl alcohol 0.4 (6) Sorbitan monostearate 1.2 (7) 1,3-butylene glycol 6.0 (8) Dipropylene glycol 4.0 (9) Polyoxyethylene ( (20EO) Sorbitan 0.8 monostearic acid ester (10) Purified water 75.9 (11) Comfrey extract 2.0 (12) Fragrance 0.1 Production method: First, the oil phase of (1) to (6) Mix, heat melt and maintain at 75 ° C. On the other hand, the aqueous phases (7) to (10) are mixed and dissolved by heating to 75 ° C., and the oil phase is added thereto with stirring to emulsify. After cooling, add (11) and (12) at 40 ° C and mix.
【0022】 [実施例3]クリーム (1)ステアリルアルコール 6.0(重量%) (2)ステアリン酸 2.0 (3)水素添加ラノリン 4.0 (4)スクワラン 9.0 (5)オクチルドデカノール 10.0 (6)ポリオキシエチレン(25EO)セチルアルコールエーテル 3.0 (7)グリセリルモノステアリン酸エステル 2.0 (8)1,3-ブチレングリコール 6.0 (9)ジエチレングリコールモノエチルエーテル 4.0 (10)精製水 50.9 (11)コンフリー抽出物 3.0 (12)香料 0.1 製法:(1)〜(7)の油相成分を混合,加熱して75℃と
する。一方、(8)〜(10)の水相成分を混合,加熱して7
5℃とし、これに前記油相を添加して乳化し、冷却後4
0℃にて(11),(12)を添加する。Example 3 Cream (1) Stearyl alcohol 6.0 (% by weight) (2) Stearic acid 2.0 (3) Hydrogenated lanolin 4.0 (4) Squalane 9.0 (5) Octyldodeca Knol 10.0 (6) polyoxyethylene (25EO) cetyl alcohol ether 3.0 (7) glyceryl monostearate 2.0 (8) 1,3-butylene glycol 6.0 (9) diethylene glycol monoethyl ether 4 0.0 (10) Purified water 50.9 (11) Comfrey extract 3.0 (12) Fragrance 0.1 Production method: Mix the oil phase components (1) to (7) and heat to 75 ° C. . On the other hand, the aqueous phase components (8) to (10) were mixed and heated to 7
The temperature was adjusted to 5 ° C., and the oil phase was added to the mixture and emulsified.
Add (11) and (12) at 0 ° C.
【0023】 [実施例4]メイクアップベースクリーム (1)ステアリン酸 12.0(重量%) (2)セタノール 2.0 (3)自己乳化型グリセリルモノステアリン酸エステル 2.0 (4)プロピレングリコール 10.0 (5)グリセリン 3.0 (6)水酸化カリウム 0.3 (7)精製水 67.6 (8)コンフリー抽出物 1.5 (9)香料 0.1 (10)二酸化チタン 1.0 (11)ベンガラ 0.1 (12)黄酸化鉄 0.4 製法:(10)〜(12)を(4)で混練し、これを(5)〜(7)の
水相に添加,混合し、70℃に加熱する。一方、(1)〜
(3)の油相成分を混合,加熱して70℃とし、これを前
記水相に攪拌しながら添加して乳化する。乳化後冷却し
て40℃にて(8),(9)を添加する。Example 4 Makeup Base Cream (1) Stearic acid 12.0 (% by weight) (2) Cetanol 2.0 (3) Self-emulsifying glyceryl monostearate 2.0 (4) Propylene glycol 10.0 (5) Glycerin 3.0 (6) Potassium hydroxide 0.3 (7) Purified water 67.6 (8) Comfrey extract 1.5 (9) Fragrance 0.1 (10) Titanium dioxide 1 0.0 (11) Bengala 0.1 (12) Yellow iron oxide 0.4 Production method: (10) to (12) are kneaded with (4), and this is added to the aqueous phase of (5) to (7). Mix and heat to 70 ° C. On the other hand, (1)-
The oil phase component of (3) is mixed and heated to 70 ° C., and this is added to the aqueous phase with stirring to emulsify. After emulsification, cool and add (8) and (9) at 40 ° C.
【0024】 [実施例5]乳液状ファンデーション (1)ステアリン酸 2.4(重量%) (2)モノステアリン酸プロピレングリコール 2.0 (3)セトステアリルアルコール 0.2 (4)液状ラノリン 2.0 (5)流動パラフィン 3.0 (6)ミリスチン酸イソプロピル 8.5 (7)グリセリルモノステアリルエーテル 3.5 (8)カルボキシメチルセルロースナトリウム 0.2 (9)ベントナイト 0.5 (10)イソプレングリコール 4.0 (11)トリエタノールアミン 1.1 (12)精製水 53.5 (13)コンフリー抽出物 1.0 (14)香料 0.1 (15)酸化チタン 8.0 (16)タルク 4.0 (17)ベンガラ 3.0 (18)黄酸化鉄 2.5 (19)黒酸化鉄 0.5 製法:(15)〜(19)の顔料を混合後、粉砕機により粉砕す
る。(12)を70℃に加熱し、(9)を加えてよく膨潤さ
せ、これにあらかじめ(8)を(10)に分散させたものを加
え、さらに(11)を添加し、溶解させる。(1)〜(7)の油
相は混合し、加熱融解して80℃とする。前記顔料を水
相に攪拌しながら加え、コロイドミルを通して75℃と
し、前記油相を攪拌しながら加えて乳化し、冷却後40
℃にて(13),(14)を添加する。Example 5 Emulsion Foundation (1) Stearic acid 2.4 (% by weight) (2) Propylene glycol monostearate 2.0 (3) Cetostearyl alcohol 0.2 (4) Liquid lanolin 0 (5) Liquid paraffin 3.0 (6) Isopropyl myristate 8.5 (7) Glyceryl monostearyl ether 3.5 (8) Sodium carboxymethyl cellulose 0.2 (9) Bentonite 0.5 (10) Isoprene glycol 4 3.0 (11) Triethanolamine 1.1 (12) Purified water 53.5 (13) Comfrey extract 1.0 (14) Fragrance 0.1 (15) Titanium oxide 8.0 (16) Talc 4. 0 (17) Bengala 3.0 (18) Yellow iron oxide 2.5 (19) Black iron oxide 0.5 Production method: After mixing the pigments of (15) to (19), the mixture is pulverized by a pulverizer. (12) is heated to 70 ° C., (9) is added to swell well, to which is added (8) previously dispersed in (10), and (11) is further added and dissolved. The oil phases (1) to (7) are mixed, heated and melted to 80 ° C. The pigment is added to the aqueous phase with stirring, the mixture is heated to 75 ° C. through a colloid mill, and the oil phase is added with stirring to emulsify.
(13) and (14) are added at ° C.
【0025】 [実施例6]クリーム状ファンデーション (1)ステアリン酸 5.0(重量%) (2)親油型グリセリルモノステアリン酸エステル 2.5 (3)モノラウリン酸プロピレングリコール 3.0 (4)セトステアリルアルコール 1.0 (5)流動パラフィン 7.0 (6)ミリスチン酸イソプロピル 8.0 (7)ジグリセリン 3.0 (8)トリエチレングリコール 2.0 (9)トリエタノールアミン 1.2 (10)精製水 44.2 (11)コンフリー抽出物 2.0 (12)香料 0.1 (13)酸化チタン 8.0 (14)カオリン 5.0 (15)タルク 2.0 (16)ベントナイト 1.0 (17)ベンガラ 2.6 (18)黄酸化鉄 2.1 (19)黒酸化鉄 0.3 製法:(13)〜(19)の顔料を混合後、粉砕機により粉砕す
る。(7)〜(10)を混合,溶解させ、加熱する。(1)〜
(6)の油相は混合し、加熱溶解して80℃とする。前記
顔料を水相に攪拌しながら加え、コロイドミルを通して
75℃とし、前記油相を攪拌しながら加えて乳化し、冷
却後40℃にて(11),(12)を添加する。Example 6 Cream Foundation (1) Stearic acid 5.0 (% by weight) (2) Lipophilic glyceryl monostearate 2.5 (3) Propylene glycol monolaurate 3.0 (4) Cetostearyl alcohol 1.0 (5) Liquid paraffin 7.0 (6) Isopropyl myristate 8.0 (7) Diglycerin 3.0 (8) Triethylene glycol 2.0 (9) Triethanolamine 1.2 ( 10) Purified water 44.2 (11) Comfrey extract 2.0 (12) Fragrance 0.1 (13) Titanium oxide 8.0 (14) Kaolin 5.0 (15) Talc 2.0 (16) Bentonite 1.0 (17) Bengala 2.6 (18) Yellow iron oxide 2.1 (19) Black iron oxide 0.3 Production method: After mixing the pigments of (13) to (19), pulverize with a pulverizer. Mix and dissolve (7) to (10) and heat. (1) ~
The oil phase of (6) is mixed and dissolved by heating to 80 ° C. The pigment is added to the aqueous phase with stirring, the mixture is heated to 75 ° C. through a colloid mill, the oil phase is added with stirring to emulsify, and after cooling, (11) and (12) are added at 40 ° C.
【0026】 [実施例7]乳化型アイカラー (1)ステアリン酸 8.0(重量%) (2)白色ワセリン 15.0 (3)パルミチン酸イソプロピル 5.0 (4)ラノリン 5.0 (5)1,3-ブチレングリコール 5.0 (6)ヘキシレングリコール 5.0 (7)トリエタノールアミン 2.0 (8)精製水 50.83 (9)コンフリー抽出物 2.5 (10)香料 0.15 (11)赤色221号 0.02 (12)群青 1.50 製法:(5)〜(8)の水相を混合,溶解して加熱し、これ
にあらかじめ混合,粉砕した(11),(12)を添加,分散
し、75℃に加熱する。これにあらかじめ混合,加熱し
て均一とした(1)〜(4)を攪拌しながら添加して乳化
し、冷却後(9)及び(10)を添加,混合する。[Example 7] Emulsifying eye color (1) Stearic acid 8.0 (wt%) (2) White petrolatum 15.0 (3) Isopropyl palmitate 5.0 (4) Lanolin 5.0 (5 ) 1,3-butylene glycol 5.0 (6) Hexylene glycol 5.0 (7) Triethanolamine 2.0 (8) Purified water 50.83 (9) Comfrey extract 2.5 (10) Fragrance 0.15 (11) Red No. 221 0.02 (12) Ultramarine blue 1.50 Production method: The aqueous phases (5) to (8) are mixed, dissolved and heated, and previously mixed and crushed (11) , (12) are added and dispersed, and heated to 75 ° C. (1) to (4), which were previously mixed and heated to make it uniform, were added with stirring to emulsify, and after cooling, (9) and (10) were added and mixed.
【0027】 [実施例8]乳化型チークカラー (1)ミツロウ 3.0(重量%) (2)ステアリン酸 2.0 (3)セタノール 3.0 (4)ラノリン 3.0 (5)流動パラフィン 15.0 (6)ミリスチン酸イソプロピル 7.0 (7)ポリオキシエチレン(20EO)ソルビタン モノステアリン酸エステル 4.2 (8)ソルビタンモノステアリン酸エステル 1.8 (9)グリセリルモノステアリン酸エステル 2.0 (10)グリセリルモノパルミチルエーテル 2.0 (11)プロピレングリコール 5.0 (12)トリエタノールアミン 0.6 (13)精製水 46.95 (14)コンフリー抽出物 2.0 (15)香料 0.15 (16)赤色202号 0.05 (17)黄酸化鉄 2.25 製法:(11)〜(13)の水相を混合,溶解して加熱し、これ
にあらかじめ混合,粉砕した(16),(17)を添加,分散
し、75℃に加熱する。これにあらかじめ混合,加熱し
て均一とした(1)〜(10)を攪拌しながら添加して乳化
し、冷却後(14),(15)を添加,混合する。Example 8 Emulsion type teak color (1) Beeswax 3.0 (% by weight) (2) Stearic acid 2.0 (3) Cetanol 3.0 (4) Lanolin 3.0 (5) Liquid paraffin 15.0 (6) Isopropyl myristate 7.0 (7) Polyoxyethylene (20EO) sorbitan monostearate 4.2 (8) Sorbitan monostearate 1.8 (9) Glyceryl monostearate 2. 0 (10) Glyceryl monopalmityl ether 2.0 (11) Propylene glycol 5.0 (12) Triethanolamine 0.6 (13) Purified water 46.95 (14) Comfrey extract 2.0 (15) Fragrance 0.15 (16) Red No. 202 0.05 (17) Yellow iron oxide 2.25 Production method: The aqueous phases (11) to (13) were mixed, dissolved, heated, and preliminarily mixed and ground. Add and disperse (16) and (17) and heat to 75 ℃ That. (1) to (10), which were previously mixed and heated to make it uniform, were added with stirring to emulsify, and after cooling, (14) and (15) were added and mixed.
【0028】 [実施例9]乳化型アイライナー (1)ステアリン酸 3.5(重量%) (2)ミツロウ 2.0 (3)カルナウバロウ 0.5 (4)マイクロクリスタリンワックス 5.0 (5)1,3-ブチレングリコール 7.0 (6)エチレングリコールモノブチルエーテル 2.5 (7)トリエタノールアミン 1.5 (8)精製水 45.9 (9)コンフリー抽出物 2.0 (10)香料 0.1 (11)3.0重量%ベントナイト抽出物 20.0 (12)酸化チタン 8.0 (13)カーボンブラック 2.0 製法:(1)〜(4)の油相成分を混合・加熱して溶解させ
る。これに(5)〜(8)の水相を混合,加熱し、攪拌しな
がら加えて乳化する。次いで、この乳化物に(11)〜(13)
を加え、コロイドミルを通して分散させた後冷却し、4
0℃にて(9),(10)を加える。Example 9 Emulsion Type Eyeliner (1) 3.5% by weight of stearic acid (2) Beeswax 2.0 (3) Carnauba wax 0.5 (4) Microcrystalline wax 5.0 (5) 1,3-butylene glycol 7.0 (6) Ethylene glycol monobutyl ether 2.5 (7) Triethanolamine 1.5 (8) Purified water 45.9 (9) Comfrey extract 2.0 (10) Fragrance 0.1 (11) 3.0% by weight bentonite extract 20.0 (12) Titanium oxide 8.0 (13) Carbon black 2.0 Production method: Mix and heat oil phase components (1) to (4) And dissolve. The aqueous phases (5) to (8) are mixed, heated, and added with stirring to emulsify. Next, (11) to (13)
, And dispersed by passing through a colloid mill, followed by cooling.
Add (9) and (10) at 0 ° C.
【0029】 [実施例10]水性懸濁型マスカラ (1)50重量%酢酸ビニルエマルション 37.0(重量%) (2)カルボキシメチルセルロースナトリウム 1.0 (3)1,3-ブチレングリコール 3.5 (4)エチレングリコールモノメチルエーテル 3.5 (5)コンフリー抽出物 3.0 (6)酸化チタン 8.0 (7)カーボンブラック 1.6 (8)ベンガラ 0.4 (9)精製水 42.0 製法;(9)に(2)〜(5)を添加して溶解させ、次いで
(6)〜(8)を添加し、コロイドミルを通して分散させ
る。これに(1)を加え、均一に分散させる。[Example 10] Aqueous suspension type mascara (1) 50% by weight of vinyl acetate emulsion 37.0 (% by weight) (2) Sodium carboxymethylcellulose 1.0 (3) 1,3-butylene glycol 3.5 (4) Ethylene glycol monomethyl ether 3.5 (5) Comfrey extract 3.0 (6) Titanium oxide 8.0 (7) Carbon black 1.6 (8) Bengala 0.4 (9) Purified water 0 Production method; (2) to (5) were added to (9) and dissolved,
(6) to (8) are added and dispersed through a colloid mill. Add (1) to this and disperse uniformly.
【0030】 [実施例11]クレンジングジェル (1)グリセリン 15.0(重量%) (2)1,3-ブチレングリコール 10.0 (3)無水ケイ酸 7.0 (4)ポリオキシエチレン(20EO)ラウリルエーテル 5.0 (5)ポリオキシエチレン(50EO)硬化ヒマシ油 2.5 (6)ジエチレングリコールモノエチルエーテル 5.0 (7)カルボキシビニルポリマー 0.5 (8)水酸化カリウム 0.45 (9)コンフリー抽出物 2.0 (10)香料 0.1 (11)精製水 52.45 製法;(3),(7)を(11)に添加し均一とした後、(1)及
び(2)に(4)〜(6)を溶解させて加え、70℃に加熱し
て均一に溶解させる。次いで冷却して40℃にて(9),
(10)を添加し、最後に(8)を加えて中和する。Example 11 Cleansing Gel (1) Glycerin 15.0 (% by weight) (2) 1,3-butylene glycol 10.0 (3) Silicic anhydride 7.0 (4) Polyoxyethylene (20EO) ) Lauryl ether 5.0 (5) Polyoxyethylene (50EO) hydrogenated castor oil 2.5 (6) Diethylene glycol monoethyl ether 5.0 (7) Carboxyvinyl polymer 0.5 (8) Potassium hydroxide 0.45 ( 9) Comfrey extract 2.0 (10) Fragrance 0.1 (11) Purified water 52.45 Production method; (3) and (7) were added to (11) to make uniform, and then (1) and ( Dissolve (4)-(6) in 2) and heat to 70 ° C. to dissolve uniformly. Then cool and at 40 ° C (9),
(10) is added, and finally (8) is added for neutralization.
【0031】 [実施例12]ヘアリンス (1)セタノール 3.0(重量%) (2)塩化ステアリルトリメチルアンモニウム 0.7 (3)シリコーン油 3.0 (4)ポリオキシエチレン(10EO)オレイルエーテル 1.0 (5)グリセリン 5.0 (6)コンフリー抽出物 1.5 (7)緑色3号1重量%水溶液 0.2 (8)香料 0.1 (9)精製水 85.5 製法;(9)に(5),(7)を加え、70℃に加熱する。一
方(1)〜(4)を混合,溶解し、70℃に加熱する。この
油相を攪拌しながら先に調製した水相に徐々に加えて予
備乳化し、ホモミキサーを加えて均一とした後冷却し、
40℃にて(6),(8)を添加する。Example 12 Hair Rinse (1) Cetanol 3.0 (% by weight) (2) Stearyltrimethylammonium chloride 0.7 (3) Silicone Oil 3.0 (4) Polyoxyethylene (10EO) Oleyl Ether 1 (5) Glycerin 5.0 (6) Comfrey extract 1.5 (7) Green No. 3 1% by weight aqueous solution 0.2 (8) Fragrance 0.1 (9) Purified water 85.5 Production method; Add (5) and (7) to 9) and heat to 70 ° C. On the other hand, (1) to (4) are mixed and dissolved, and heated to 70 ° C. This oil phase was gradually added to the previously prepared aqueous phase while stirring, and pre-emulsified, homogenized by adding a homomixer, and then cooled,
At 40 ° C., (6) and (8) are added.
【0032】 [実施例13]ヘアトリートメント (1)ポリオキシエチレン(30EO)ベへニルエーテル 4.0(重量%) (2)自己乳化型グリセリルモノステアレート 6.0 (3)ミリスチン酸イソプロピル 5.0 (4)ヘキシルデカノール 5.0 (5)スクワラン 3.0 (6)精製ラノリン 3.0 (7)ステアリン酸 5.0 (8)ラウリルジメチルアミノ酢酸ベタイン 5.0 (9)グリセリン 10.0 (10)精製水 52.8 (11)香料 0.2 (12)コンフリー抽出物 1.0 製法:(1)〜(7)の油相成分を混合,加熱して80℃と
する。一方、(8)〜(10)の水相成分を混合,加熱して8
5℃とし、これに前記油相を添加して乳化し、冷却後4
0℃にて(11)及び(12)を添加する。Example 13 Hair Treatment (1) Polyoxyethylene (30EO) behenyl ether 4.0 (% by weight) (2) Self-emulsifying glyceryl monostearate 6.0 (3) Isopropyl myristate 0 (4) hexyldecanol 5.0 (5) squalane 3.0 (6) purified lanolin 3.0 (7) stearic acid 5.0 (8) lauryl dimethylaminoacetate betaine 5.0 (9) glycerin 10.0 ( 10) Purified water 52.8 (11) Fragrance 0.2 (12) Comfrey extract 1.0 Production method: Mix and heat the oil phase components (1) to (7) to 80 ° C. On the other hand, the aqueous phase components (8) to (10) were mixed and heated to 8
The temperature was adjusted to 5 ° C., and the oil phase was added to the mixture and emulsified.
At 0 ° C. add (11) and (12).
【0033】 [実施例14]洗顔料 (1)ステアリン酸 10.0(重量%) (2)パルミチン酸 10.0 (3)ミリスチン酸 12.0 (4)ラウリン酸 4.0 (5)オレイルアルコール 1.5 (6)ラノリンアルコール 1.0 (7)水酸化カリウム 6.0 (8)精製水 44.4 (9)1,3-ブチレングリコール 10.0 (10)香料 0.1 (11)コンフリー抽出物 1.0 製法:(1)〜(6)の油相及び(7)〜(9)の水相をそれぞ
れ75℃に混合加熱溶解した後、油相に水相を加えてケ
ン化する。冷却後40℃で(10)及び(11)を添加して混合
する。Example 14 Face Wash (1) Stearic acid 10.0 (% by weight) (2) Palmitic acid 10.0 (3) Myristic acid 12.0 (4) Lauric acid 4.0 (5) Oleyl Alcohol 1.5 (6) Lanolin alcohol 1.0 (7) Potassium hydroxide 6.0 (8) Purified water 44.4 (9) 1,3-butylene glycol 10.0 (10) Fragrance 0.1 (11 ) Comfrey extract 1.0 Production method: After mixing and dissolving the oil phase of (1) to (6) and the aqueous phase of (7) to (9) at 75 ° C., add an aqueous phase to the oil phase. Saponify. After cooling, add (10) and (11) at 40 ° C. and mix.
【0034】 [実施例15]ボディシャンプー (1)ラウリン酸 5.0(重量%) (2)ミリスチン酸 7.5 (3)ラウロイルジエタノールアミド 5.0 (4)グリセリン 20.0 (5)水酸化カリウム(10重量%水溶液) 3.0 (6)精製水 58.7 (7)コンフリー抽出物 0.5 (8)香料 0.3 製法:(1)〜(3)の油相及び(4)〜(6)の水相をそれぞ
れ75℃に混合加熱溶解した後、油相に水相を加えてケ
ン化する。冷却後40℃で(7)及び(8)を添加して混合
する。Example 15 Body Shampoo (1) Lauric acid 5.0 (% by weight) (2) Myristic acid 7.5 (3) Lauroyl diethanolamide 5.0 (4) Glycerin 20.0 (5) Water Potassium oxide (10% by weight aqueous solution) 3.0 (6) Purified water 58.7 (7) Comfrey extract 0.5 (8) Fragrance 0.3 Production method: Oil phase of (1) to (3) and ( After mixing and dissolving each of the aqueous phases 4) to 6) at 75 ° C., the aqueous phase is added to the oil phase for saponification. After cooling, add (7) and (8) at 40 ° C. and mix.
【0035】次に、上記の実施例1〜15について、抗
菌活性,皮膚刺激性及び使用時の不快感について評価を
行った。同時に表1に示す比較例についても同様に抗菌
活性の評価を行った。Next, the above Examples 1 to 15 were evaluated for antibacterial activity, skin irritation and discomfort during use. At the same time, the comparative examples shown in Table 1 were similarly evaluated for antibacterial activity.
【0036】[0036]
【表1】 [Table 1]
【0037】(1)抗菌活性の評価 細菌として大腸菌
(Escherichia coli),黄色ブドウ球菌(Staphylococc
us aureus)及び緑濃菌(Pseudomonas aeruginosa)
を、真菌としてカンジダ(Candida albicans)及び黒カビ
(Aspergillus niger)を用い、試料1g当たり細菌は
106個,真菌は105個を植菌し、37℃及び25℃で
それぞれ培養して、2週間後の生菌数を測定した。な
お、抗菌活性は2週間後に、細菌については死滅した場
合、真菌については生菌数が1/1000以下となった
場合に合格であると判断した。なお抗菌力試験結果は、
表2及び表3において合格したものを「○」、不合格の
ものを「×」として示した。(1) Evaluation of antibacterial activity As bacteria, Escherichia coli and Staphylococc
us aureus ) and Pseudomonas aeruginosa
Using Candida albicans and black mold ( Aspergillus niger ) as fungi, inoculating 10 6 bacteria and 10 5 fungi per gram of the sample, culturing at 37 ° C. and 25 ° C., respectively, for 2 weeks The number of viable bacteria was measured later. In addition, the antibacterial activity was judged to be acceptable when the bacteria died after 2 weeks, and when the viable count of the fungi became 1/1000 or less, the bacteria passed. The results of the antibacterial test
In Tables 2 and 3, those that passed were indicated by “「 ”, and those that failed were indicated by“ x ”.
【0038】[0038]
【表2】 [Table 2]
【0039】[0039]
【表3】 [Table 3]
【0040】表2において明らかなように、本発明の実
施例においては、いずれも細菌及び真菌の双方に対して
十分な抗菌活性が認められていた。これに対し表3に示
した通り、コンフリー抽出物のみを含有する比較例2,
5,7,9,11,13及び15においては、ほとんど
の試験菌に対して抗菌活性が認められていなかった。ま
た、多価アルコール又はそのアルキルエーテルのみを含
有する比較例1,3,4,6,8,10,12および1
4においても、一部又は全ての試験菌に対し合格基準を
満たしていなかった。As is clear from Table 2, in Examples of the present invention, sufficient antibacterial activity against both bacteria and fungi was observed. In contrast, as shown in Table 3, Comparative Example 2 containing only the comfrey extract
In 5,7,9,11,13 and 15, no antibacterial activity was observed for most test bacteria. Comparative Examples 1, 3, 4, 6, 8, 10, 12 and 1 containing only a polyhydric alcohol or its alkyl ether
Also in No. 4, some or all of the test bacteria did not meet the acceptance criteria.
【0041】(2)皮膚刺激性の評価 各試料について、
男性パネラー30名を用いて、48時間閉塞貼付試験を
行い、表4に示す判定基準により評価し、30名の皮膚
刺激指数の平均値を求めた。なお、実施例11〜実施例
15については、1.0重量%水溶液を試験に用いた。(2) Evaluation of skin irritation For each sample,
Using 30 male panelists, a 48-hour obstruction sticking test was performed, evaluated according to the criteria shown in Table 4, and the average value of the skin irritation index of 30 persons was obtained. In Examples 11 to 15, a 1.0% by weight aqueous solution was used for the test.
【0042】[0042]
【表4】 [Table 4]
【0043】(3)使用時の不快感の評価 女性パネラー
20名を1群とし、各群に各試料をそれぞれ使用させ、
塗布後30秒から1分間の間に感じる刺すような痛み,
ヒリヒリ感,チクチク感といった不快感について評価さ
せた。評価結果は、「非常に強く感じる;5点」,「や
や強く感じる;4点」,「感じる;3点」,「少し感じ
る;2点」,「微妙に感じる;1点」,「感じない;0
点」として評価し、20名の平均値にて示した。この際
にも、実施例11〜実施例15については、1.0重量
%水溶液を試験に用いた。以上の結果を表5にまとめて
示した。(3) Evaluation of discomfort during use Twenty female panelists were divided into one group, and each group was allowed to use each sample.
Stinging pain felt between 30 seconds and 1 minute after application,
Discomfort such as burning and tingling were evaluated. The evaluation results were "very strong; 5 points", "somewhat strong; 4 points", "feeling; 3 points", "slightly feeling; 2 points", "subtle feeling; 1 point", and "not feeling". ; 0
The score was evaluated as “point”, and indicated by the average value of 20 persons. Also in this case, for Examples 11 to 15, a 1.0% by weight aqueous solution was used for the test. Table 5 summarizes the above results.
【0044】[0044]
【表5】 [Table 5]
【0045】表5において、本発明の実施例について
は、いずれにおいても皮膚刺激性は認められておらず、
使用時の不快感も微妙に感じられる程度である。In Table 5, no skin irritation was observed in any of the examples of the present invention.
Discomfort during use is also subtle.
【0046】[0046]
【発明の効果】以上詳述したように、本発明により、抗
菌作用が相乗的に強化され、しかも皮膚刺激性のみなら
ず、使用時の刺すような痛み,ヒリヒリ感,チクチク感
といった不快感もほとんど感じられない抗菌性化粧料を
得ることができた。As described above in detail, according to the present invention, the antibacterial action is synergistically enhanced, and not only skin irritation but also discomfort such as stinging, tingling and tingling when used. It was possible to obtain an antibacterial cosmetic which was hardly felt.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 FI A61K 7/06 A61K 7/06 7/075 7/075 7/08 7/08 7/50 7/50 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 6 Identification code FI A61K 7/06 A61K 7/06 7/075 7/075 7/08 7/08 7/50 7/50
Claims (7)
ルキルエーテルより選ばれる1種又は2種以上と、ヒレ
ハリソウ属植物の抽出物を併用することを特徴とする、
抗菌性低刺激化粧料。1. A method comprising using one or more selected from polyhydric alcohols and alkyl ethers of polyhydric alcohols with an extract of a plant of the genus Valerian.
Antibacterial hypoallergenic cosmetic.
分子内に4個以下の水酸基を有するものから選ばれるこ
とを特徴とする、請求項1に記載の抗菌性低刺激化粧
料。2. One or more polyhydric alcohols are:
The antibacterial hypoallergenic cosmetic according to claim 1, wherein the cosmetic is selected from those having 4 or less hydroxyl groups in a molecule.
種又は2種以上が、エチレングリコール,ジエチレング
リコール,トリエチレングリコールのモノ及びジアルキ
ルエーテル、プロピレングリコール,ジプロピレングリ
コールのモノ及びジアルキルエーテル、グリセリンのモ
ノ,ジ及びトリアルキルエーテルより選ばれることを特
徴とする、請求項1又は請求項2に記載の抗菌性低刺激
化粧料。3. An alkyl ether of a polyhydric alcohol.
The species or two or more species are selected from mono and dialkyl ethers of ethylene glycol, diethylene glycol and triethylene glycol, mono and dialkyl ethers of propylene glycol and dipropylene glycol, and mono, di and trialkyl ethers of glycerin. The antibacterial and hypoallergenic cosmetic according to claim 1 or 2.
抽出物であることを特徴とする、請求項1〜請求項3に
記載の抗菌性低刺激化粧料。4. The antibacterial anti-irritant cosmetic according to claim 1, wherein the extract of the genus Valeriana is a polar solvent extract.
ル抽出物であることを特徴とする、請求項1〜請求項4
に記載の抗菌性低刺激化粧料。5. The method according to claim 1, wherein the extract of Valerian plant is an ethanol extract.
2. The antibacterial and hypoallergenic cosmetic according to item 1.
ngtonia officinaleL.)エタノール抽出物であることを
特徴とする、請求項1〜請求項5に記載の抗菌性低刺激
化粧料。6. The plant of the genus Valeriana is comfrey ( Symi
ngtonia officinale L.) An antimicrobial anti-irritant cosmetic according to any one of claims 1 to 5, which is an ethanol extract.
ngtonia officinaleL.)の葉のエタノール抽出物である
ことを特徴とする、請求項1〜請求項6に記載の抗菌性
低刺激化粧料。7. The plant of the genus Valeriana is comfrey ( Symi
The antibacterial anti-irritant cosmetic according to any one of claims 1 to 6, wherein the cosmetic is an ethanol extract of leaves of Ngtonia officinale L.)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9017514A JPH10194917A (en) | 1997-01-14 | 1997-01-14 | Antimicrobial and low-irritating cosmetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9017514A JPH10194917A (en) | 1997-01-14 | 1997-01-14 | Antimicrobial and low-irritating cosmetic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH10194917A true JPH10194917A (en) | 1998-07-28 |
Family
ID=11946087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9017514A Pending JPH10194917A (en) | 1997-01-14 | 1997-01-14 | Antimicrobial and low-irritating cosmetic |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH10194917A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005120057A (en) * | 2003-10-20 | 2005-05-12 | Shiseido Co Ltd | Mascara composition |
| JP2005336180A (en) * | 2004-05-04 | 2005-12-08 | Cognis Ip Management Gmbh | Glycerol ether mixture, cosmetic composition containing the mixture, and method for producing the same |
| JP2007091687A (en) * | 2005-09-30 | 2007-04-12 | Asanuma Corporation | Liquid cosmetics |
| JP2010523563A (en) * | 2007-04-02 | 2010-07-15 | アビラ,アルフレド | Herbal preparations for the treatment of fractures and bone defects |
-
1997
- 1997-01-14 JP JP9017514A patent/JPH10194917A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005120057A (en) * | 2003-10-20 | 2005-05-12 | Shiseido Co Ltd | Mascara composition |
| JP2005336180A (en) * | 2004-05-04 | 2005-12-08 | Cognis Ip Management Gmbh | Glycerol ether mixture, cosmetic composition containing the mixture, and method for producing the same |
| JP2007091687A (en) * | 2005-09-30 | 2007-04-12 | Asanuma Corporation | Liquid cosmetics |
| JP2010523563A (en) * | 2007-04-02 | 2010-07-15 | アビラ,アルフレド | Herbal preparations for the treatment of fractures and bone defects |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101217382B1 (en) | EXTERNAL DERMATOLOGICAL FORMULATION COMPRISING SACCHARIDE DERIVATIVE OF α,α-TREHALOSE | |
| JPH08119825A (en) | Hydroxytyrosol, application for skin external medicine or bathing agent | |
| JPH0940523A (en) | Fibroblast proliferation promoter containing water extract form chlorella | |
| JP3758794B2 (en) | Collagen production promoter and anti-aging skin external preparation containing the same | |
| JP3615894B2 (en) | Antibacterial hypoallergenic cosmetic | |
| JP2002114670A (en) | Antimicrobial skin care preparation | |
| JP4070065B2 (en) | Skin preparation for preventing and improving skin roughness | |
| JP2002003358A (en) | Skin care preparation | |
| JP2003335621A (en) | Antifungal low irritative cosmetic | |
| JPH11255612A (en) | Antibacterial agent and antibacterial composition | |
| JP3630384B2 (en) | Antibacterial hypoallergenic cosmetic | |
| JPH10203954A (en) | Antimicrobial low-irritating cosmetic | |
| JP3573883B2 (en) | Antibacterial hypoallergenic cosmetics | |
| JPH11302147A (en) | Cosmetic | |
| JPH10203991A (en) | Preparation for external use for skin | |
| JPH10194916A (en) | Antimicrobial and low-irritating cosmetic | |
| JP3562781B2 (en) | Antibacterial hypoallergenic cosmetics | |
| JPH10182335A (en) | Antimicrobial and low-irritation cosmetic | |
| JP3757368B2 (en) | Antibacterial hypoallergenic cosmetic | |
| JP4500906B2 (en) | Cosmetic compounding agent and cosmetics containing the same | |
| JP2003238429A (en) | Fibroblast cell-activating agent and skin external agent containing the same | |
| JPH107582A (en) | Skin lotion | |
| JP3586519B2 (en) | Antibacterial hypoallergenic cosmetics | |
| JP2002121110A (en) | Cosmetic | |
| JP2021185879A (en) | Yeast culture extract and skin preparation containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20040802 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20041119 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20050322 |